Cargando…

Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism

Detalles Bibliográficos
Autores principales:	Mouton-Liger, François, Rebillat, Anne-Sophie, Gourmaud, Sarah, Leguen, Audrey, Paquet, Claire, Pradier, Laurent, Rooney, Thomas, Hugon, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846720/ http://dx.doi.org/10.1186/1750-1326-8-S1-P31

Ejemplares similares

PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model
por: Mouton-Liger, F, et al.
Publicado: (2015)

Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice
por: Mouton-Liger, François, et al.
Publicado: (2013)

PKR involvement in Alzheimer’s disease
por: Hugon, Jacques, et al.
Publicado: (2017)

Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation
por: Carret-Rebillat, Anne-Sophie, et al.
Publicado: (2015)

PKR modulates abnormal brain signaling in experimental obesity
por: Taga, Mariko, et al.
Publicado: (2018)

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease
por: Dumurgier, Julien, et al.
Publicado: (2013)

PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions
por: Tible, Marion, et al.
Publicado: (2019)

The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease
por: Hugon, Jacques, et al.
Publicado: (2021)

Blood-Based Kinase Assessments in Alzheimer’s Disease
por: Hugon, Jacques, et al.
Publicado: (2018)

Are ketogenic diets promising for Alzheimer’s disease? A translational review
por: Lilamand, Matthieu, et al.
Publicado: (2020)

Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
por: Moynier, Frédéric, et al.
Publicado: (2020)

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
por: Mouton-Liger, François, et al.
Publicado: (2020)

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
por: Vrillon, Agathe, et al.
Publicado: (2022)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
por: Lilamand, Matthieu, et al.
Publicado: (2022)

Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review
por: Lilamand, Matthieu, et al.
Publicado: (2022)

Editorial: Channel Modulation in Neurodegeneration and Neuroprotection
por: Joubert, Jacques, et al.
Publicado: (2022)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
por: Cognat, Emmanuel, et al.
Publicado: (2019)

Hepatitis C Virus Controls Interferon Production through PKR Activation
por: Arnaud, Noëlla, et al.
Publicado: (2010)

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication
por: Clerzius, Guerline, et al.
Publicado: (2013)

pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain
por: Kim, Sehwan, et al.
Publicado: (2023)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neurodegeneration and Neuroprotection in Diabetic Retinopathy
por: Ola, Mohammad Shamsul, et al.
Publicado: (2013)

Inhibition of PKR by Viruses
por: Cesaro, Teresa, et al.
Publicado: (2021)

Neurodegeneration, Neuroprotection and Regeneration in the Zebrafish Retina
por: Stella, Salvatore L., et al.
Publicado: (2021)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

PKR: A Kinase to Remember
por: Gal-Ben-Ari, Shunit, et al.
Publicado: (2019)

Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT
por: Dabo, Stephanie, et al.
Publicado: (2017)

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
por: Paquet, Claire, et al.
Publicado: (2016)

Neuroprotective strategies against calpain-mediated neurodegeneration
por: Yildiz-Unal, Aysegul, et al.
Publicado: (2015)

Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration
por: Vega, Irving E., et al.
Publicado: (2016)

Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
por: Mahalakshmi, B., et al.
Publicado: (2020)

New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection
por: Turner, A.J., et al.
Publicado: (2007)

Interaction of PKR with single-stranded RNA
por: Mayo, Christopher B., et al.
Publicado: (2017)

PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
por: Mouton-Liger, Francois, et al.
Publicado: (2017)

HIV-1 replication changes the function of the PKR activator PACT
por: Clerzius, Guerline, et al.
Publicado: (2013)

All-you-can-eat: autophagy in neurodegeneration and neuroprotection
por: Jaeger, Philipp A, et al.
Publicado: (2009)

Neuroprotective Function of 14-3-3 Proteins in Neurodegeneration
por: Shimada, Tadayuki, et al.
Publicado: (2013)

Neuroprotective Effects of Citicoline in in Vitro Models of Retinal Neurodegeneration
por: Matteucci, Andrea, et al.
Publicado: (2014)

Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection
por: Erdener, Şefik Evren, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vafqi67evau0brf3nv5hvb15c8